Manganese oxide nanomaterials boost cancer immunotherapy
- 26 June 2021
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (35) , 7117-7131
Abstract
Immunotherapy, a strategy that leverages the host immune function to fight against cancer, plays an increasingly important role in clinical tumor therapy. In spite of the great success achieved in not only clinical treatment but also basic research, cancer immunotherapy still faces many huge challenges. Manganese oxide nanomaterials (MONs), as ideal tumor microenvironment (TME)-responsive biomaterials, are able to dramatically elicit anti-tumor immune responses in multiple ways, indicating great prospects for immunotherapy. In this review, on the basis of different mechanisms to boost immunotherapy, major highlighted topics are presented, covering adjusting an immunosuppressive TME by generating O2 (like O2-sensitized photodynamic therapy (PDT), programmed cell death ligand-1 (PD-L1) expression downregulation, reprogramming tumor-associated macrophages (TAMs), and restraining tumor angiogenesis and lactic acid exhaustion), inducing immunogenic cell death (ICD), photothermal therapy (PTT) induction, activating the stimulator of interferon gene (STING) pathway and immunoadjuvants for nanovaccines. We hope that this review will provide holistic understanding about MONs and their application in cancer immunotherapy, and thus pave the way to the translation from bench to bedside in the future.Keywords
Funding Information
- National Natural Science Foundation of China (51720105015, 51929201, 51922097, 51772124, 51872282)
- Chinese Academy of Sciences (YZDY-SSW-JSC018)
- Youth Innovation Promotion Association of the Chinese Academy of Sciences (2017273)
- China Postdoctoral Science Foundation (BX2021360)
- Ministry of Science and Technology of the People's Republic of China (2017YFE0132300)
This publication has 104 references indexed in Scilit:
- Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapyBiomaterials, 2013
- Immunogenic cell death and DAMPs in cancer therapyNature Reviews Cancer, 2012
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Cancer immunotherapy comes of ageNature, 2011
- Intracellular Glutathione Detection Using MnO2-Nanosheet-Modified Upconversion NanoparticlesJournal of the American Chemical Society, 2011
- Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticityNature Medicine, 2011
- Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvantsNature, 2008
- Calreticulin exposure dictates the immunogenicity of cancer cell deathNature Medicine, 2006
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Cancer immunotherapy: moving beyond current vaccinesNature Medicine, 2004